Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Patient Safety and Risk Management
PS-078
THERAPEUTIC EDUCATION OF THE PATIENT: THE ROLE OF THE HOSPITAL PHARMACIST
PS-077
DOSE OPTIMISATION OF OMALIZUMAB IN PATIENTS WITH SEVERE PERSISTENT ALLERGIC ASTHMA
PS-072
DOES THE COMPUTERISED PHYSICIAN ORDER ENTRY SYSTEM REDUCE PRESCRIBING ERRORS FOR INPATIENTS? A BEFORE AND AFTER STUDY
PS-070
EVALUATION OF A PROGRAMME OF MEDICATION RECONCILIATION AT HOSPITAL ADMISSION IN TRAUMA PATIENTS REQUIRING SURGERY
PS-069
EVALUATION OF POST-CHEMOTHERAPY TOXICITIES IN CANCER PATIENTS WHO ATTENDED THE EMERGENCY SERVICE
PS-068
EVALUATION OF THE INCIDENCE AND THE CONSEQUENCES OF THE EXTRAVASATION OF CHEMOTHERAPY DRUGS IN A TERTIARY HOSPITAL
PS-067
INAPPROPRIATE USE OF PROTON PUMP INHIBITORS AMONG ELDERLY PEOPLE: AUDIT IN A GERIATRIC HOSPITAL
PS-066
INFUSION REACTIONS DOCUMENTED WITH DIFFERENT GENERIC PACLITAXEL FORMULATIONS BY MEANS OF AN ADVERSE DRUG REACTIONS REPORTING PROGRAMME
PS-065
IVABRADINE PRESCRIPTION ACCORDING TO PHARMACOVIGILANCE RISK ASSESSMENT COMMITTEE RESTRICTIONS
PS-064
MEDICATION ERRORS IN AN EMERGENCY DEPARTMENT OBSERVATION UNIT
PS-063
MEDICATION LABEL DESIGN AND PATIENT SAFETY: AN INTERACTIVE COMPARISON TEST
PS-062
DESENSITISATION PROTOCOL FOR CABAZITAXEL: A CASE REPORT
PS-058
ANALYSIS OF PHARMACEUTICAL INTERVENTIONS IN THE ONCO-HAEMATOLOGY AREA IN A TERTIARY LEVEL HOSPITAL
PS-056
PRIORITISATION OF PATIENTS FOR MEDICATION RECONCILIATION: APPLICATION IN PATIENTS HOSPITALISED IN THE EMERGENCY UNIT
PS-054
USE OF CONTRAINDICATED DRUGS IN PARKINSON’S DISEASE PATIENTS
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
Follow Us